- Home
- Site Contents
- Our Founder
- Governance
- Faculty
- Strategic Plan
- Core Values
- Resources
- Programs - Research
- Programs - Education
- Programs - Service
- Clinical Trials
- Other Activities
- Press Releases (1980-90)
- Press Releases (2000-10)
- Press Releases (2010-15)
- Press Releases (2015-20)
- Press Releases (2021)
- Press Releases (2022)
- Conferences (2013-7)
- Conferences (2018)
- Conferences (2019)
- Conferences (2020)
- Conferences (2021)
- Conferences (2022)
- Patents
- Books & Monographs
- Book Contributions
- Refereed Articles - 1
- Refereed Articles -2
- Refereed Articles - 3
- Refereed Articles - 4
- Abstracts: 2013-17
- Abstracts: 2018-19
- Abstracts: 2020-21
- Abstracts: 2022-23
- Philanthropy
- Privacy Policy
- Blank
ABSTRACTS: 2020-2021
2020
A. L. Fymat, Nanobiotechnology-Based Drugs for Treatment of Neurological Disorders, Invited Lecture Presentation at 6thEuropean Biopharma Congress, Amsterdam, The Netherlands., September 18-19, 2018. Journal of Pharmaceutical Bioprocessing 8(3):1-3, 2020.
A.L. Fymat, What Do We Know About Lewy Body Dementias, 2ndInternational Conference on Dementia and Dementia Care, Montreal, Canada, August 20-21, 2020.
A. L. Fymat, Exploring the Innovation and Excellence in the Field of Graphene Technologies and Carbon Nanotubes, Awards 2020, Open Access Journal of Engineering & Management 8:4, Milan Italy, 23-24 September 2020.
A. L. Fymat, Predicting and Preventing the next Pandemics,Keynote presented at the 7thAnnual International Conference of the Society for the Advancement of Science, Kampala, Uganda, October 26, 2020.
A. L. Fymat, Global Market Analysis on Nanomedicine and Drug Delivery Systems,presented at the 2nd European Congress on Nanomedicine and Drug Delivery Systems. Paris, France, 7-8 December 2020.
2021
A. L. Fymat, Nanobiotechnology for treatment of neurological disorders, 23rd International Conference on Pharmaceutical Biotechnology, 2021.
A. L. Fymat, Nanobiotechnology Roles in Brain Cancer Treatment, Invited Keynote Lecture, 6th European Biopharma Congress, New York, New York, USA, 5 April 2021.
A. L. Fymat, Roles of Nanotechnology in the Treatment of Glioblastomas and Neurological Diseases, Second International Conference and Exhibition on Pharmacology and Pharmaceutical Research, Dubai, UAE, April 23-24, 2021.
A. L. Fymat, Nanopharmacology in the Treatment of Neurodegenerative Disorders, International Pharmaceutical Research and Drug Development (GPD 2021) Conference, Prague, Czech Republic, May 14-15, 2021.
A. L. Fymat, Dementia : What do we know about the disease and what can be done about it? International Conference on Dementia, Singapore City, Singapore, June 21-22, 2021.
A. L. Fymat, On Alzheimer's Cure: 19 Important Questions Answered, Invited Keynote at the Fifth International Conference on Neurology & Therapeutics (Neurology 2021), Paris, France, July 7-8, 2021.
A. L. Fymat, Paradigm for pandemic prediction and prevention, presented at the European Union Academy of Sciences Pandemics (e2021 Symposium), Brussels, Belgium, July 15, 2021.
A. L. Fymat, Dementia: Is its root cause a runaway autoimmune disease? Geriatric & Gerontology Conference 2021, October 21-23, 2021, Prague, Czech Republic (converted to virtual).
A. L. Fymat, Glioblastoma surgical and non-surgical treatments: What progress made? Surgery 2021 International Conference & Exhibition on Surgery and Anesthesia, 2-4 December 2021, London, U.K.
2022
A. L. Fymat, On the surgical and non-surgical treatments of glioblastomas, International Conference on Surgery, 25-26 February 2022, Bangkok, Thailand.
A. L. Fymat, COVID-19 neurological manifestations, 2022 Neurology International Conference, Paris, France, April 25-26, 2022.
2023
2023
2024
2024
2025
2025